日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/12/21 | 7,320 | 7,330 | 7,000 | 7,000 | -320 | -4.4% | 235,800 |
| 2018/12/20 | 7,550 | 7,590 | 7,310 | 7,320 | -240 | -3.2% | 235,900 |
| 2018/12/19 | 7,450 | 7,590 | 7,420 | 7,560 | +110 | +1.5% | 255,500 |
| 2018/12/18 | 7,520 | 7,550 | 7,300 | 7,450 | -250 | -3.2% | 281,400 |
| 2018/12/17 | 7,710 | 7,760 | 7,520 | 7,700 | -130 | -1.7% | 415,000 |
| 2018/12/14 | 7,790 | 7,910 | 7,720 | 7,830 | +40 | +0.5% | 377,200 |
| 2018/12/13 | 7,550 | 7,860 | 7,550 | 7,790 | +270 | +3.6% | 291,600 |
| 2018/12/12 | 7,340 | 7,550 | 7,330 | 7,520 | +240 | +3.3% | 327,400 |
| 2018/12/11 | 7,440 | 7,470 | 7,260 | 7,280 | -120 | -1.6% | 198,900 |
| 2018/12/10 | 7,380 | 7,430 | 7,320 | 7,400 | -90 | -1.2% | 152,700 |
| 2018/12/07 | 7,480 | 7,570 | 7,410 | 7,490 | ±0 | ±0% | 186,500 |
| 2018/12/06 | 7,610 | 7,610 | 7,380 | 7,490 | -160 | -2.1% | 174,700 |
| 2018/12/05 | 7,490 | 7,680 | 7,480 | 7,650 | +40 | +0.5% | 137,400 |
| 2018/12/04 | 7,750 | 7,840 | 7,590 | 7,610 | -220 | -2.8% | 222,200 |
| 2018/12/03 | 7,860 | 7,910 | 7,780 | 7,830 | +70 | +0.9% | 145,100 |
| 2018/11/30 | 7,620 | 7,810 | 7,600 | 7,760 | +110 | +1.4% | 199,400 |
| 2018/11/29 | 7,850 | 7,930 | 7,640 | 7,650 | -60 | -0.8% | 358,700 |
| 2018/11/28 | 7,780 | 7,790 | 7,510 | 7,710 | +40 | +0.5% | 258,000 |
| 2018/11/27 | 7,630 | 7,710 | 7,580 | 7,670 | +110 | +1.5% | 310,900 |
| 2018/11/26 | 7,550 | 7,620 | 7,510 | 7,560 | -40 | -0.5% | 166,200 |
| 2018/11/22 | 7,520 | 7,630 | 7,450 | 7,600 | +220 | +3% | 214,800 |
| 2018/11/21 | 7,330 | 7,410 | 7,270 | 7,380 | -10 | -0.1% | 227,500 |
| 2018/11/20 | 7,390 | 7,480 | 7,310 | 7,390 | -50 | -0.7% | 243,400 |
| 2018/11/19 | 7,310 | 7,540 | 7,300 | 7,440 | -20 | -0.3% | 271,700 |
| 2018/11/16 | 7,500 | 7,580 | 7,420 | 7,460 | -10 | -0.1% | 242,500 |
| 2018/11/15 | 7,400 | 7,530 | 7,350 | 7,470 | +130 | +1.8% | 220,000 |
| 2018/11/14 | 7,290 | 7,420 | 7,230 | 7,340 | -60 | -0.8% | 243,400 |
| 2018/11/13 | 7,400 | 7,520 | 7,290 | 7,400 | -80 | -1.1% | 424,800 |
| 2018/11/12 | 7,280 | 7,550 | 7,270 | 7,480 | +150 | +2% | 425,100 |
| 2018/11/09 | 7,210 | 7,390 | 7,190 | 7,330 | +150 | +2.1% | 422,200 |
| 2018/11/08 | 6,840 | 7,220 | 6,840 | 7,180 | +590 | +9% | 458,000 |
| 2018/11/07 | 6,650 | 6,780 | 6,510 | 6,590 | -50 | -0.8% | 377,000 |
| 2018/11/06 | 6,500 | 6,690 | 6,500 | 6,640 | +150 | +2.3% | 163,000 |
| 2018/11/05 | 6,550 | 6,590 | 6,460 | 6,490 | -80 | -1.2% | 176,900 |
| 2018/11/02 | 6,470 | 6,590 | 6,410 | 6,570 | +120 | +1.9% | 345,900 |
| 2018/11/01 | 6,500 | 6,620 | 6,420 | 6,450 | -60 | -0.9% | 218,500 |
| 2018/10/31 | 6,450 | 6,540 | 6,310 | 6,510 | +30 | +0.5% | 214,400 |
| 2018/10/30 | 6,360 | 6,520 | 6,360 | 6,480 | +110 | +1.7% | 180,800 |
| 2018/10/29 | 6,430 | 6,550 | 6,360 | 6,370 | -20 | -0.3% | 120,600 |
| 2018/10/26 | 6,580 | 6,590 | 6,310 | 6,390 | -140 | -2.1% | 210,600 |
| 2018/10/25 | 6,560 | 6,620 | 6,510 | 6,530 | -190 | -2.8% | 205,800 |
| 2018/10/24 | 6,630 | 6,740 | 6,610 | 6,720 | +160 | +2.4% | 270,100 |
| 2018/10/23 | 6,850 | 6,850 | 6,550 | 6,560 | -390 | -5.6% | 284,000 |
| 2018/10/22 | 6,840 | 6,990 | 6,810 | 6,950 | +60 | +0.9% | 163,400 |
| 2018/10/19 | 6,820 | 6,980 | 6,790 | 6,890 | -150 | -2.1% | 249,200 |
| 2018/10/18 | 7,050 | 7,160 | 7,010 | 7,040 | +80 | +1.1% | 239,300 |
| 2018/10/17 | 6,850 | 6,960 | 6,650 | 6,960 | +210 | +3.1% | 298,100 |
| 2018/10/16 | 6,710 | 6,830 | 6,690 | 6,750 | -40 | -0.6% | 256,600 |
| 2018/10/15 | 6,850 | 6,880 | 6,760 | 6,790 | -120 | -1.7% | 254,900 |
| 2018/10/12 | 7,060 | 7,160 | 6,890 | 6,910 | -240 | -3.4% | 266,400 |
1551～
1600
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 341,400円 | +7.9% | +8.9% | 3.63% | 7.30倍 | 0.98倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 433,100円 | +20.9% | +87.3% | 3.14% | 9.67倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 189,400円 | +5.0% | +1.5% | 0.00% | 16.25倍 | 4.32倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 199,600円 | +4.0% | +25.4% | 2.66% | 8.73倍 | 1.15倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 397,500円 | +3.6% | +6.1% | 2.26% | 14.54倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
